stoxline Quote Chart Rank Option Currency Glossary
  
BioLife Solutions, Inc. (BLFS)
27.77  0.63 (2.32%)    02-14 16:00
Open: 27.33
High: 27.98
Volume: 293,756
  
Pre. Close: 27.14
Low: 26.8
Market Cap: 1,288(M)
Technical analysis
2025-02-14 4:46:41 PM
Short term     
Mid term     
Targets 6-month :  34.51 1-year :  40.31
Resists First :  29.54 Second :  34.51
Pivot price 27.07
Supports First :  26.59 Second :  24.77
MAs MA(5) :  26.8 MA(20) :  27.13
MA(100) :  25.5 MA(250) :  22.59
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  42.7 D(3) :  34.8
RSI RSI(14): 56.8
52-week High :  29.54 Low :  14.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BLFS ] has closed below upper band by 29.1%. Bollinger Bands are 16.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 28.02 - 28.13 28.13 - 28.24
Low: 26.52 - 26.65 26.65 - 26.76
Close: 27.57 - 27.77 27.77 - 27.95
Company Description

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

Headline News

Sun, 16 Feb 2025
Biolife Solutions executive sells shares worth $2,441 - MSN

Sun, 16 Feb 2025
BioLife Solutions chief HR officer sells $1,406 in stock - MSN

Fri, 14 Feb 2025
Biolife Solutions' chief quality and operations officer sells $2,070 in stock By Investing.com - Investing.com South Africa

Fri, 14 Feb 2025
Stephens Investment Management Group LLC Grows Position in BioLife Solutions, Inc. (NASDAQ:BLFS) - MarketBeat

Wed, 12 Feb 2025
Recent Price Trend in BioLife Solutions (BLFS) is Your Friend, Here's Why - Yahoo Finance

Sat, 08 Feb 2025
Swelling losses haven't held back gains for BioLife Solutions (NASDAQ:BLFS) shareholders since they're up 71% over 5 years - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 0 (M)
Shares Float 46 (M)
Held by Insiders 3.61e+007 (%)
Held by Institutions 1.8 (%)
Shares Short 3,130 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.8e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -31.4 %
Return on Assets (ttm) -5.1 %
Return on Equity (ttm) -6 %
Qtrly Rev. Growth 1.4696e+008 %
Gross Profit (p.s.) 15.79
Sales Per Share -8
EBITDA (p.s.) 2.93351e+007
Qtrly Earnings Growth -1.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 9 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 184.3
Price to Book value 0
Price to Sales -3.48
Price to Cash Flow 7.41
Stock Dividends
Dividend 0
Forward Dividend 3.32e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android